Form 8-K - Current report:
SEC Accession No. 0001140361-07-016410
Filing Date
2007-08-14
Accepted
2007-08-14 16:48:09
Documents
3
Period of Report
2007-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 BIOSANTE 8K FOR 6-30-07 q120078k.htm 8-K 25425
2 PRESS RELEASE pressrelease8-14.htm EX-99.1 15364
3 LOGO biosantelogo6.jpg GRAPHIC 36068
  Complete submission text file 0001140361-07-016410.txt   92275
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 071056127
SIC: 2836 Biological Products, (No Diagnostic Substances)